As already mentioned in the context of breast cancer, this could be due to low ephrin expression, an impaired EphA2-ephrin-A1 interaction due to loss of cadherin, or dephosphorylation of Tyr772 by LMW-PTP [8,51,52]. This evidence concerns the gene EPHA2 and breast cancer.